Aiforia is happy to announce the win of this contract award, which enables us to offer our AI solutions directly for 25 NHS Trusts pathology departments in the UK. Aiforia has received a contract award to provide artificial intelligence...

Mindpeak breast cancer algorithms have been seamlessly integrated into the gold-standard image management software, CaloPix 5, enhancing the pathologist's possibilities. PARIS, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Tribun Health, the European...

Paige: Company announces CE-IVD and UKCA designations of its new digital biomarker assay, HER2Complete, to identify patients with expression of HER2 in breast cancer The tool has revealed HER2 expression in HER2-negative and HER2-low...

Aiforia Technologies Plc announces the CE-IVD marking of the Aiforia® Clinical AI Model for Prostate Cancer; Gleason Grade Groups. This latest regulatory certification brings Aiforia’s portfolio of AI-powered diagnostic tools to a total of 5...

Paige now holds six CE marks in its portfolio of clinical AI applications Paige Breast Lymph Node was first launched at the United States and Canadian Academy of Pathology (USCAP) Annual Meeting in March 2022 NEW YORK--(BUSINESS...

Proscia and Visiopharm: Partnership to improve clinical decision making for breast and colon cancer care HOERSHOLM, Denmark & PHILADELPHIA – March 22, 2022 – Proscia®, a leader in digital and computational pathology solutions, and...